Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, reflecting a site/software release rather than a change to the underlying clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:29:23.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added revision: v3.5.2 and removed revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:05.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now active, replacing v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T08:38:56.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T04:18:17.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding lapse notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T16:39:07.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    A government funding status notice banner was added and the page revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:47:30.000Z thumbnail image

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.